T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Dollar General
DG
|
+$1.37B |
| 2 |
Intel
INTC
|
+$1.28B |
| 3 |
SCHW
Charles Schwab
SCHW
|
+$1B |
| 4 |
Nike
NKE
|
+$859M |
| 5 |
Uber
UBER
|
+$825M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$2.67B |
| 2 |
Amazon
AMZN
|
+$2.15B |
| 3 |
NVIDIA
NVDA
|
+$1.64B |
| 4 |
Humana
HUM
|
+$1.57B |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$1.33B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.09% |
| 2 | Healthcare | 15.81% |
| 3 | Financials | 11.13% |
| 4 | Consumer Discretionary | 10.82% |
| 5 | Communication Services | 8.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2801
NuScale Power
SMR
$4.03B
| $53K | ﹤0.01% |
15,715
+896
| +6% | +$3.19K |
|
|
QIPT
2802
DELISTED
Quipt Home Medical
QIPT
| $52K | ﹤0.01% |
+10,189
| New | +$48.8K |
|
2803
Vroom Inc
VRM
$51.2M
| $52K | ﹤0.01% |
1,073
+503
| +88% | +$32.8K |
|
2804
Nerdy
NRDY
$94.9M
| $50K | ﹤0.01% |
14,325
+1,179
| +9% | +$3.62K |
|
2805
Cue Biopharma
CUE
$131M
| $49K | ﹤0.01% |
608
+53
| +10% | +$3.79K |
|
|
WOW
2806
DELISTED
WideOpenWest
WOW
| $49K | ﹤0.01% |
11,884
+652
| +6% | +$3.51K |
|
2807
SelectQuote
SLQT
$130M
| $48K | ﹤0.01% |
34,859
+5,371
| +18% | +$7.01K |
|
|
VINC
2808
DELISTED
Vincerx Pharma, Inc. Common Stock
VINC
| $48K | ﹤0.01% |
2,000
| – | – |
|
|
MMAT
2809
DELISTED
Meta Materials Inc. Common Stock
MMAT
| $48K | ﹤0.01% |
7,186
+4,640
| +182% | +$55.5K |
|
2810
Emergent Biosolutions
EBS
$237M
| $47K | ﹤0.01% |
19,534
+1,339
| +7% | +$3.15K |
|
2811
Aqua Metals
AQMS
$9.85M
| $46K | ﹤0.01% |
299
| – | – |
|
2812
CorMedix
CRMD
$613M
| $46K | ﹤0.01% |
12,073
| – | – |
|
|
TEAD
2813
Teads Holding Co
TEAD
$63.8M
| $46K | ﹤0.01% |
+10,291
| New | +$43.6K |
|
2814
Ovid Therapeutics
OVID
$517M
| $46K | ﹤0.01% |
14,251
+837
| +6% | +$2.86K |
|
2815
Veru
VERU
$45.5M
| $46K | ﹤0.01% |
6,330
+3,800
| +150% | +$33.7K |
|
2816
Barnwell Industries
BRN
$13.9M
| $45K | ﹤0.01% |
18,200
| – | – |
|
2817
Heron Therapeutics
HRTX
$61.8M
| $45K | ﹤0.01% |
25,931
+5,127
| +25% | +$5.64K |
|
2818
PEDEVCO
PED
$161M
| $45K | ﹤0.01% |
2,875
| – | – |
|
2819
Outdoor Holding Co
POWW
$259M
| $45K | ﹤0.01% |
21,132
+2,136
| +11% | +$4.87K |
|
|
VXRT
2820
DELISTED
Vaxart
VXRT
| $45K | ﹤0.01% |
78,500
| – | – |
|
|
CMAX
2821
DELISTED
CareMax, Inc. Class A Common Stock
CMAX
| $45K | ﹤0.01% |
2,986
+82
| +3% | +$3.4K |
|
2822
BlackSky Technology
BKSY
$1.27B
| $44K | ﹤0.01% |
3,908
+705
| +22% | +$7.15K |
|
2823
Humacyte
HUMA
$157M
| $44K | ﹤0.01% |
15,448
+1,512
| +11% | +$3.88K |
|
|
KZR
2824
DELISTED
Kezar Life Sciences
KZR
| $44K | ﹤0.01% |
4,635
| – | – |
|
|
NSTG
2825
DELISTED
NanoString Technologies, Inc.
NSTG
| $44K | ﹤0.01% |
58,259
+19,500
| +50% | +$20.6K |
|
Similar funds
T. Rowe Price Associates's Q4 2023 Portfolio in Review
As of Q4 2023, T. Rowe Price Associates held 2,974 positions worth $744B, up 9.1% from $682B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
T. Rowe Price Associates's Q4 2023 filing shows 92 new, 1,834 increased, 805 reduced and 67 closed positions. Its largest new stake was Canadian Natural Resources: 6,473,658 shares worth $212M. The largest sale was Microsoft, an estimated $2.67B.
By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 30% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q4 2023 buy was Canadian Natural Resources: 6,473,658 shares worth $212M.
- T. Rowe Price Associates added most to Dollar General in Q4 2023, an estimated $1.37B increase.
- T. Rowe Price Associates's biggest Q4 2023 reduction was Microsoft, cutting an estimated $2.67B.
- T. Rowe Price Associates fully exited Activision Blizzard in Q4 2023, selling an estimated $293M.
- T. Rowe Price Associates's ten largest holdings make up 31% of its $744B portfolio in Q4 2023.
- T. Rowe Price Associates opened 92 new positions and closed 67 in Q4 2023.
- T. Rowe Price Associates's portfolio value rose 9.1% quarter-over-quarter to $744B.
Based on T. Rowe Price Associates's 13F filing for Q4 2023, filed 14 Feb 2024.